Condition
Tyrosine Kinase Inhibitor clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Tyrosine Kinase Inhibitor clinical trials that are recruiting, at sites in 3 countries (most in China (2), Netherlands (2), Italy (1)). By phase: Phase 4 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 3Countries
Newest Tyrosine Kinase Inhibitor clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| TASTY training to improve taste and smell for people taking tyrosine kinase inhibitors | — | Amsterdam and 10 other locations | Recruiting | Dec 2, 2025 |
| High-dose firmonertinib plus chemotherapy injected into the spinal fluid for EGFR-mutant NSCLC with leptomeningeal spread | Phase 4 | Wuhan, Hubei | Recruiting | Jul 29, 2025 |
| Tyrosine kinase inhibitors and erectile dysfunction in men with chronic myeloid leukemia | — | Reggio Emilia, RE | Recruiting | Jul 11, 2025 |
| Combining Befotertinib with Bevacizumab or Chemotherapy for Lung Cancer Treatment | Phase 2 | Shanghai, Shanghai Municipality | Recruiting | Jan 1, 2025 |
| Collecting blood samples from lung cancer patients on targeted therapy | — | Rotterdam | Recruiting | Feb 3, 2022 |
All recruiting trials (5)
-
TASTY training to improve taste and smell for people taking tyrosine kinase inhibitors
This trial tests whether a 12-week at-home taste and smell training program helps adults who developed taste changes after starting tyrosine kinase inhibitor treatment.
-
High-dose firmonertinib plus chemotherapy injected into the spinal fluid for EGFR-mutant NSCLC with leptomeningeal spread
This tests whether high-dose firmonertinib combined with chemotherapy injected into the spinal fluid helps people with EGFR-mutant non-small cell lung cancer that has spread to the leptomeninges.
-
Tyrosine kinase inhibitors and erectile dysfunction in men with chronic myeloid leukemia
This will see if taking tyrosine kinase inhibitors for chronic myeloid leukemia is linked to erectile dysfunction in adult men.
-
Combining Befotertinib with Bevacizumab or Chemotherapy for Lung Cancer Treatment
This study is testing if a new lung cancer treatment combining befotertinib with either bevacizumab or chemotherapy can help patients with early-stage cancer that has an EGFR mutation feel better before surgery.
-
Collecting blood samples from lung cancer patients on targeted therapy
This study is collecting blood samples from adults with non-small cell lung cancer who are on targeted therapy to see how their treatment is working and to check for any changes in their cancer.
Related topics
Quick answers
How many Tyrosine Kinase Inhibitor clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in China (2 trials), Netherlands (2 trials), Italy (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.